sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608

Europe Cancer Chemotherapy Market Size & Forecast

Download Free Sample View Report Summary
Historic: 2021-2023 Base Year: 2024 Forecast: 2025–2031
US$ 11,680.2 Million
Market Size 2024 · Base Year
US$ 23,140.5 Million
Projected Market Size by 2031
10.4%
CAGR · 2025–2031
Download Free Sample View Report Summary
sales@businessmarketinsights.com +1 646 791 7070 | +91-020 69018608
SHARE
BMIPUB00033455 23+ Countries Covered 10 Major Companies Profiled PEST & SWOT Analysis Competitive Heat Map
At a Glance

Report Coverage

56 +
Countries
23+ countries across Europe
11
Year Assessment
Comprehensive Market Analysis Covering 3 Years of Historical Data (2021–2023), Base Year (2024), and 7-Year Forecast (2025–2031)
10 +
Major Players
Major companies profiled including Astellas Pharma Inc, Eli Lilly and Co, Novartis AG, Merck KGaA, Johnson & Johnson
293
Report Pages
Pages of deep-dive analysis with PEST, SWOT, competitive heat maps and datasets
What's Fueling Growth

Market Drivers

  • Comprehensive Care with Surgery, Radiation, and Targeted Agents

  • Increased use of chemotherapy in maintenance therapy

  • Expansion of comprehensive cancer treatment centers

Where Growth Opportunities Exist

Key Opportunities

  • AI-Enabled Optimization of Chemotherapy Regimens

  • Expansion of digital oncology management platforms

  • Increasing investment in precision oncology solutions

What Could Slow It Down

Market Restraints

  • Long approval timelines for novel chemotherapy drugs

  • High cost burden on public healthcare systems

Market Segmentation

Coverage by Segment

Therapy Type

Alkylating Agents
Antimetabolites
Anti-Tumor Antibiotics

Indication

Blood Cancer
Lung Cancer
Breast Cancer

End User

Hospital Pharmacies
Retail Pharmacies
Online Stores
Geographic Breakdown

Regional Intelligence

NA North America
EU Europe
APAC Asia-Pacific
SCA South & Central America
MEA Middle East & Africa
Competitive Landscape

Major Market Players

Listed for reference — companies are not ranked in any particular order.

Astellas Pharma Inc
Eli Lilly and Co
Novartis AG
Merck KGaA
Johnson & Johnson
AstraZeneca
Pfizer Inc
Bristol Myers Squibb
F. Hoffmann-La Roche Ltd
AbbVie
What's Inside

Report Scope & Deliverables

Market Size 2024 US$ 11,680.2 Million
Market Size 2031 US$ 23,140.5 Million
CAGR 2025–2031 10.4%
Segments By Therapy Type (Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics)  |  By Indication (Blood Cancer, Lung Cancer, Breast Cancer)  |  By End User (Hospital Pharmacies, Retail Pharmacies, Online Stores)
Geographies Europe (Belgium, Austria, Finland, Denmark, Greece, Poland, Romania, Russia, Ukraine, Czech Republic, Slovakia, Bulgaria, Italy, Luxembourg, Germany, Switzerland, France, Netherlands, Norway, Portugal, Spain, Sweden, United Kingdom)
Deliverables Historical analysis with CAGR · PEST & SWOT analysis · Market Size at Global, Regional, and Country Levels · Competitive heat map · Company profiles · Excel dataset
Report Code BMIPUB00033455
Lead Analyst Krishna Sunthwal — Analyst, Research · View Profile
With Full Report Access

Gain actionable insights with 293 pages of in-depth Europe Cancer Chemotherapy Market, including historical trends, 7-year market forecasts, SWOT analysis, competitive landscapes, and downloadable Excel datasets in a single comprehensive package.

View Report Summary Download Free Sample